Prognostic Factor Analysis and Nomogram Development in Castration-Resistant Prostate Cancer with Visceral Metastases for Future Radionuclide Therapy Selection

列线图 医学 前列腺癌 肿瘤科 内科学 比例危险模型 临床终点 置信区间 一致性 多元分析 单变量 单变量分析 前瞻性队列研究 回顾性队列研究 危险系数 队列 生存分析 放射性核素治疗 癌症 性能状态 多元统计 预测模型 代理终结点 肾癌 临床试验 血液学 总体生存率 放射治疗 生化复发 不利影响
作者
Pengfei Xu,Xianfu Lin,Yunhai Zhu,Jinyuan Chen,Bo Yang
出处
期刊:Cancer Biotherapy and Radiopharmaceuticals [Mary Ann Liebert, Inc.]
卷期号:: 10849785261460356-10849785261460356
标识
DOI:10.1177/10849785261460356
摘要

Objective: To identify independent prognostic factors in castration-resistant prostate cancer (CRPC) patients with visceral metastases, construct and internally validate a prognostic nomogram for individualized risk stratification, and generate a hypothesis-driven framework that may inform future candidate selection for radionuclide therapies—including lutetium-177 PSMA-617 ( 177 Lu-PSMA-617) and radium-223 dichloride ( 223 Ra)—pending prospective targeted radionuclide therapy (TRT)-specific validation. Methods: A retrospective cohort study was conducted on 98 CRPC patients with imaging-confirmed visceral metastases treated at the institution from January 2017 to December 2023. Baseline demographics, tumor parameters, laboratory biomarkers, and treatment data were systematically collected. The primary endpoint was overall survival (OS); the secondary endpoint was progression-free survival (PFS). Kaplan–Meier analysis, univariate and multivariate Cox proportional hazards regression models, and a six-factor prognostic nomogram were used. Model performance was assessed by Concordance Index (C-index), bootstrap-corrected calibration curves (1000 iterations), and time-dependent receiver operating characteristic analysis. Results: Among 98 patients (median age 68 years), median follow-up was 19.2 months, with 72 deaths (73.5%). Median OS was 13.2 months (95% confidence interval [CI]: 11.5–15.0 months); median PFS was 7.5 months (95% CI: 6.6–8.5 months). Six independent adverse prognostic factors for OS were identified: Eastern Cooperative Oncology Group performance status (ECOG PS) ≥2 (hazard ratio [HR] = 1.89, p < 0.001), multiorgan visceral metastases (HR = 1.52, p = 0.008), alkaline phosphatase ≥240 U/L (HR = 1.58, p = 0.004), hemoglobin <110 g/L (HR = 1.45, p = 0.024), albumin <35 g/L (HR = 1.62, p = 0.004), and prostate-specific antigen decline <50% (HR = 1.78, p < 0.001). The nomogram achieved a C-index of 0.712 (OS) and 0.698 (PFS); time-dependent area under the curve (AUC) ranged from 0.672 to 0.748 across 6–24 months. Conclusions: CRPC patients with visceral metastases carry a dismal prognosis. The six-factor nomogram provides a quantitative prognostic framework that may support evidence-based risk stratification in this high-risk subpopulation. Important to note that no patient in this cohort received radionuclide therapy; the model is derived from a non-TRT cohort and should be regarded as hypothesis generating. Its utility as a TRT selection instrument warrants prospective validation in cohorts receiving 177 Lu-PSMA-617 or 223 Ra. Integration with molecular biomarkers—prostate-specific membrane antigen (PSMA) expression quantification, AR-V7 status, and DNA damage repair profiling—remains essential for future validation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
skbz完成签到,获得积分10
刚刚
winnie完成签到,获得积分10
1秒前
灭法者发布了新的文献求助20
1秒前
xua完成签到,获得积分10
1秒前
Ma发布了新的文献求助10
1秒前
wali完成签到 ,获得积分0
1秒前
麻辣火锅完成签到 ,获得积分10
1秒前
自由绮兰完成签到,获得积分10
2秒前
Everything完成签到,获得积分10
2秒前
trying完成签到,获得积分10
2秒前
花海211完成签到,获得积分10
2秒前
完美世界的应助被正直的黑猫采纳,获得10
2秒前
云山完成签到,获得积分10
2秒前
corn完成签到 ,获得积分10
2秒前
ZSW完成签到,获得积分10
3秒前
Clark完成签到,获得积分0
3秒前
瞌睡虫子完成签到 ,获得积分10
3秒前
小米粥完成签到,获得积分10
4秒前
路灯下的小伙完成签到,获得积分0
4秒前
sarah完成签到,获得积分10
4秒前
manman完成签到,获得积分10
4秒前
Janus完成签到,获得积分10
4秒前
5秒前
Ninomae完成签到,获得积分10
5秒前
风吹麦浪的应助被怕黑的缘分采纳,获得10
6秒前
77完成签到,获得积分10
6秒前
芙蕖星星完成签到,获得积分10
6秒前
皇帝的床帘完成签到,获得积分10
6秒前
再见了杀小妹完成签到,获得积分10
7秒前
7秒前
7秒前
DW的应助被刘洋采纳,获得10
7秒前
leecopper001完成签到,获得积分10
7秒前
489695发布了新的文献求助10
7秒前
852的应助被从容从露采纳,获得10
7秒前
青羽落霞完成签到,获得积分10
7秒前
秋风的应助被CY采纳,获得20
8秒前
yuhui完成签到,获得积分10
8秒前
fangzheng完成签到,获得积分0
8秒前
领导范儿的应助被石榴采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180407
求助须知:如何正确求助?哪些是违规求助? 9570403
关于积分的说明 21811831
捐赠科研通 7776452
什么是DOI,文献DOI怎么找? 3433277
关于科研通互助平台的介绍 2557499
邀请新用户注册赠送积分活动 2479105